Trials / Completed
CompletedNCT01672606
Effect of Rocuronium on the Acute Hypoxic Ventilatory Response in Patients With Obstructive Sleep Apnea
Effect of Partial Neuromuscular Blockade by Rocuronium on the Acute Hypoxic Ventilatory Response in Patients With Obstructive Sleep Apnea-before and After Three Month CPAP Treatment. A Non-randomized, Non-blinded Study.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Malin Jonsson Fagerlund · Academic / Other
- Sex
- Male
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study describe the effect of partial neuromuscular blockade of rocuronium on the acute hypoxic ventilatory response in patients with OSA before and after 3 month of CPAP treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rocuronium | Partial neuromuscular blockade with rocuronium with a TOF 0.70 |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2016-02-01
- Completion
- 2016-02-01
- First posted
- 2012-08-27
- Last updated
- 2016-02-29
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT01672606. Inclusion in this directory is not an endorsement.